This webpage was last updated on: 02 Mar 2021 16:57:27.683
|
Clinical Pathway
|
Recommended Action
|
|
Routine outpatients New
|
Clinical review and most are being cancelled including paed derm video clinics. Will all be cancelled when required
|
|
Routine outpatient Follow up
|
Either moved to telephone clinic or cancelled including CNS clinics. Review patient on biologics f2f
|
|
Rapid access
|
To continue to be seen as normal in clinic
|
|
Patch
|
Do next week clinics – then cancel
|
|
PDT
|
Cancelled
|
|
Photo
|
Cancelled
|
|
Routine Surgery Day Surgery & outpatients
|
Urgent and skin cancers
|
|
Rapid access surgery outpatients
|
Clinically reviewed and only operating on the highest risk patients, those that can be delayed will be
|
|
Inpatient referrals
|
Will be managed via advice and guidance firstly ask for photos and only seen if necessary
|
|
At- risk patients
|
Identify those patients with reduced immunity as per Royal college guidance and BAD guidance.
|
|
Vulnerable patients
|
Patients who are receiving conventional disease-modifying drugs including biologics and novel small molecule immunosuppressants such as Apremilast will be reviewed on case by case.
Biologics will continue.
Oral medication and s/c methotrexate will continue
|
|
Homecare delivery services
|
To liaise with pharmacy
|
|
Day case patients
|
To continue Biologics on MTU
|
| |
|